Back to top

Novo Nordisk upgraded to Buy from Hold at Nordea

Nordea upgraded Novo Nordisk (NVO) to Buy from Hold with a DKK 350 price target The firm believes the near-term news flow “looks positively skewed....

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

NOV Inc. (NOV)

Novo Nordisk A/S (NVO)